GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of GNPX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Genprex Inc. stock price up 0.425% on Thursday
(Updated on Apr 18, 2024)

Sell candidate since Apr 15, 2024 Loss -5.56% PDF

The Genprex Inc. stock price gained 0.425% on the last trading day (Thursday, 18th Apr 2024), rising from $2.21 to $2.22. During the last trading day the stock fluctuated 4.13% from a day low at $2.18 to a day high of $2.27. The price has fallen in 7 of the last 10 days and is down by -25.77% for this period. Volume fell on the last day by -3 thousand shares and in total, 17 thousand shares were bought and sold for approximately $38.73 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 9.69% during the next 3 months and, with a 90% probability hold a price between $0.800 and $7.92 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

GNPX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Genprex Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.49 and $3.36. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, February 05, 2024, and so far it has fallen -66.87%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Genprex Inc. stock

Genprex Inc. finds support from accumulated volume at $2.21 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0900 between high and low, or 4.13%. For the last week the stock has had daily average volatility of 10.75%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GNPX) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Genprex Inc. to open at $2.22, and during the day (based on 14 day Average True Range), to move between $1.90 and $2.53, which gives a possible trading interval of +/-$0.315 (+/-14.20%) up or down from last closing price. If Genprex Inc. takes out the full calculated possible swing range there will be an estimated 28.40% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.21 (0.42%) than the resistance at $2.35 (5.88%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Genprex Inc. stock A Buy?

The Genprex Inc. stock holds several negative signals and despite the positive trend, we believe Genprex Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.896 Sell Candidate Unchanged

Predicted Opening Price for Genprex Inc. of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$2.22 ( 0.168%) $2.22

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for GNPX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.31 4.22 %
R2 2.28 2.67 %
R1 2.26 1.72 %
Current price: 2.22
Support S1 2.19 -1.38 %
S2 2.17 -2.34 %
S3 2.13 -3.89 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.74 23.46 %
R2 2.71 22.11 %
R1 2.35 5.88 %
Current price 2.22
Support S1 2.21 -0.424%
S2 0 .
S3 0 .

FAQ

What is the symbol for Genprex Inc. Stock and on which exchange is it traded?
The symbol for Genprex Inc. is GNPX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Genprex Inc. Stock?
The Genprex Inc. stock holds several negative signals and despite the positive trend, we believe Genprex Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Genprex Inc. Stock?
Genprex Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Genprex Inc. Stock.

What's the current price of Genprex Inc. Stock?
As of the end of day on the 2024-04-18, the price of an Genprex Inc. (GNPX) share was $2.22.

What is the 52-week high and low for Genprex Inc. Stock?
The 52-week high for Genprex Inc. Stock is $7.99 and the 52-week low is $0.183.

What is the market capitalization of Genprex Inc. Stock?
As of the 2024-04-18, the market capitalization of Genprex Inc. is 4.222M.

When is the next earnings date for Genprex Inc.?
The upcoming earnings date for Genprex Inc. is May 27, 2024.
Click to get the best stock tips daily for free!

About Genprex Inc.

Genprex. Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.... GNPX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT